PanGenomic Health, Inc. Class A's market cap is currently C$1.41M. The company's EPS TTM is C$-1.733; its P/E ratio is ―; PanGenomic Health, Inc. Class A is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -681.43K	C$ -11.11K	C$ -2.13K	C$ 0.00	C$ 0.00
Operating Income	C$ -2.71M	C$ -3.64M	C$ -852.81K	C$ -136.95K	C$ -72.00
EBITDA	C$ -2.71M	C$ -3.57M	C$ -847.50K	C$ -1.81K	C$ -3.37K
Net Income	C$ -2.97M	C$ -20.35M	C$ -2.65M	C$ -139.99K	C$ -3.44K
Balance Sheet
Cash & Short-Term Investments	C$ 12.56K	C$ 88.53K	C$ 1.35M	C$ 38.23K	C$ 2.24K
Total Assets	C$ 71.48K	C$ 504.14K	C$ 2.58M	C$ 147.22K	C$ 5.61K
Total Debt	C$ 964.75K	C$ 101.77K	C$ 0.00	C$ 27.50K	C$ 0.00
Net Debt	C$ 952.19K	C$ 13.24K	C$ -1.35M	C$ -10.73K	C$ -2.24K
Total Liabilities	C$ 2.22M	C$ 719.25K	C$ 334.45K	C$ 136.27K	C$ 3.17K
Stockholders' Equity	C$ -2.14M	C$ -215.11K	C$ 2.24M	C$ 10.95K	C$ 2.44K
Cash Flow
Free Cash Flow	C$ -1.57M	C$ -2.79M	C$ -1.07M	C$ -37.52K	-
Operating Cash Flow	C$ -1.57M	C$ -2.78M	C$ -1.06M	C$ -37.52K	-
Investing Cash Flow	C$ -3.14K	C$ -52.13K	C$ -604.91K	C$ -100.00K	C$ 0.00
Financing Cash Flow	C$ 1.50M	C$ 1.57M	C$ 2.97M	C$ 173.50K	C$ 0.00

Currency in CAD

PanGenomic Health, Inc. Class A Earnings and Revenue History

Income Statement >

PanGenomic Health, Inc. Class A Debt to Assets

Balance Sheet >

PanGenomic Health, Inc. Class A Cash Flow

Cash Flow >

PanGenomic Health, Inc. Class A Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing